Armon R. Sharei
Ph.D. Board Member
Armon is Founder and CEO of Portal Biotechnologies and formerly the CEO and Founder of SQZ Biotechnologies (NYSE: SQZ), where he led the company from invention to post-IPO with over $300M in equity financing, a $1Bn collaboration with Roche, and three clinical trials. He graduated from Stanford University, CA BS, with Honors and Distinction, Chemical Engineering, Ph.D. in Chemical Engineering, Massachusetts Institute of Technology, MA. Post-Doctoral Fellow, Immunology at Harvard Medical School, MA.